Treatment of hypertension with fluoxetine and l-5-hydroxytryptophane
Patent 4329356 Issued on May 11, 1982. Estimated Expiration Date: 
October 31, 2000. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
October 31, 2000. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesAryloxyphenylpropylamines in treating depression Process for promoting analgesia Aryloxyphenylpropylamines for obtaining a psychotropic effect Patent #: 4194009 InventorAssigneeApplicationNo. 06/202847 filed on 10/31/1980US Classes:514/419C=X bonded directly or indirectly by an acyclic carbon or carbon chain to ring carbon of the five-membered hetero ring (e.g., tryptophan, etc.) (X is chalcogen)ExaminersPrimary: Fagelson, Anna P.Attorney, Agent or FirmInternational ClassesA61K 31/403 (20060101)A61K 31/405 (20060101) AbstractFluoxetine alone or a combination of fluoxetine and l-5-hydroxytryptophan, preferably also with a peripheral decarboxylase inhibitor, is administered to hypertensive mammals to lower blood pressure.Other References
| |
